Table 1.
Clinical characteristics of patients with IgAN at the time of biopsy.
| Pt ID |
Sex | Age (years) |
sCr (μmol/L) |
eGFR (ml/min per 1.73 m2) |
UPCR (mg/mmol Cr) |
Hypertension (Y/N) |
On RAAS blocker (Y/N) |
On Corticosteroid (Y/N) |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 71 | 92 | 70 | 77 | Y | Y | N |
| 2 | F | 58 | 81 | 63 | 189 | Y | Y | N |
| 3 | F | 28 | 202 | 26 | 113 | N | Y | N |
| 4 | M | 60 | 82 | 83 | 540 | N | N | N |
| 5 | F | 54 | 73 | 72 | 99 | N | Y | N |
eGFR, estimated glomerular filtration rate; IgAN, IgA nephropathy; Pt, patient; RAAS, Renin-angiotensin-aldosterone system; sCr, serum creatinine; UPCR, spot urine protein-to-creatinine ratio.